These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1884495)

  • 1. Metabolic imaging of patients with cardiomyopathy.
    Geltman EM
    Circulation; 1991 Sep; 84(3 Suppl):I265-72. PubMed ID: 1884495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of fatty acid metabolism with positron emission tomography in patients with cardiomyopathy.
    Sochor H; Schelbert HR; Schwaiger M; Henze E; Phelps ME
    Eur J Nucl Med; 1986; 12 Suppl():S66-9. PubMed ID: 3490381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of myocardial fatty acid metabolism with 1-11C-palmitate.
    Geltman EM
    J Nucl Cardiol; 1994; 1(2 Pt 2):S15-22. PubMed ID: 9420693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered regional myocardial metabolism in congestive cardiomyopathy detected by positron tomography.
    Geltman EM; Smith JL; Beecher D; Ludbrook PA; Ter-Pogossian MM; Sobel BE
    Am J Med; 1983 May; 74(5):773-85. PubMed ID: 6601460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of ischemic from nonischemic cardiomyopathy with positron emission tomography.
    Eisenberg JD; Sobel BE; Geltman EM
    Am J Cardiol; 1987 Jun; 59(15):1410-4. PubMed ID: 3496001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of myocardial glucose utilization of hypertrophic and dilated cardiomyopathy using 18F-2-fluoro 2-deoxy-D-glucose and positron emission tomography].
    Ohtake T; Kosaka N; Watanabe T; Momose T; Nishikawa J; Sasaki Y; Iio M; Yokoyama I; Iizuka M; Sugimoto T
    Nihon Rinsho; 1991 Jan; 49(1):143-7. PubMed ID: 2002593
    [No Abstract]   [Full Text] [Related]  

  • 7. Positron-emission tomography and cardiomyopathy.
    Sobel BE
    Postgrad Med J; 1992; 68 Suppl 1():S24-8. PubMed ID: 1409211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial metabolic changes in hypertrophic cardiomyopathy.
    Tadamura E; Tamaki N; Matsumori A; Magata Y; Yonekura Y; Nohara R; Sasayama S; Yoshibayashi M; Kamiya T; Konishi J
    J Nucl Med; 1996 Apr; 37(4):572-7. PubMed ID: 8691242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of the ischemic origin of dilated myocardiopathy using positron emission tomography].
    Ruiz Salmerón RJ; Jurado López JA; San Martín Gómez MA; Pérez-Castejón MJ; Díaz-Buschmann I; Parra Jiménez FJ; García de la Villa B; Pérez Blasco P; Pasalodos Pita J; Carreras Delgado JL; Medina Peralta J; García García A; Mateos García M
    Rev Esp Cardiol; 1998; 51 Suppl 1():67-76. PubMed ID: 9549401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial glucose metabolism in patients with hypertrophic cardiomyopathy: assessment by F-18-FDG PET study.
    Uehara T; Ishida Y; Hayashida K; Shimonagata T; Miyake Y; Sago M; Oka H; Nagata S; Miyatake K; Nishimura T
    Ann Nucl Med; 1998 Apr; 12(2):95-103. PubMed ID: 9637280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of thallium-201 myocardial single-photon emission computed tomography and cine magnetic resonance imaging in Duchenne's muscular dystrophy.
    Miyoshi K; Fujikawa K
    Am J Cardiol; 1995 Jun; 75(17):1284-6. PubMed ID: 7778561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myocardial fatty acid metabolic imaging using C-11 labeled palmitate].
    Tamaki N; Kawamoto M; Yonekura Y; Magata Y; Konishi J
    Nihon Rinsho; 1991 Jan; 49(1):148-54. PubMed ID: 2002594
    [No Abstract]   [Full Text] [Related]  

  • 13. [Planar scintigraphy versus PET in measuring fatty acid metabolism of the heart].
    Kaiser KP; Feinendegen LE
    Herz; 1987 Feb; 12(1):41-50. PubMed ID: 3493962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of ventricular function and myocardial oxidative metabolism in nonischemic dilated cardiomyopathy.
    Bach DS; Beanlands RS; Schwaiger M; Armstrong WF
    J Am Coll Cardiol; 1995 May; 25(6):1258-62. PubMed ID: 7722118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional myocardial metabolic rate of oxygen measured by O2-15 inhalation and positron emission tomography in patients with cardiomyopathy.
    Agostini D; Iida H; Takahashi A; Tamura Y; Henry Amar M; Ono Y
    Clin Nucl Med; 2001 Jan; 26(1):41-9. PubMed ID: 11139052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. omega-123I-hexadecanoic acid metabolic probe of cardiomyopathy.
    Rabinovitch MA; Kalff V; Allen R; Rosenthal A; Albers J; Das SK; Pitt B; Swanson DP; Mangner T; Rogers WL
    Eur J Nucl Med; 1985; 10(5-6):222-7. PubMed ID: 4039270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial accumulation of monoclonal antimyosin Fab in hypertrophic cardiomyopathy and postpartum cardiomyopathy.
    Nakata T; Gotoh M; Yonekura S; Tanaka S; Shimamoto K; Kubota M; Tsuda T; Iimura O
    J Nucl Med; 1991 Dec; 32(12):2291-4. PubMed ID: 1744720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of myocardial metabolism with 11C-palmitate. Comparison with 123I-heptadecanoic acid.
    Lerch RA; Bergmann SR
    Eur Heart J; 1985 Aug; 6 Suppl B():21-7. PubMed ID: 3878785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial contrast echocardiography in chronic ischemic and nonischemic cardiomyopathies.
    Monakier D; Woo A; Vannan MA; Rakowski H
    Cardiol Clin; 2004 May; 22(2):269-82. PubMed ID: 15158939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pathologic correlation with PET in ischemic and nonischemic cardiomyopathy.
    Berry JJ; Hoffman JM; Steenbergen C; Baker JA; Floyd C; Van Trigt P; Hanson MW; Coleman RE
    J Nucl Med; 1993 Jan; 34(1):39-47. PubMed ID: 8418269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.